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Edited by Felix WielandAbstract Rab27a and melanophilin (Mlph) are required in vivo
to form a melanosome receptor for myosin Va in which Rab27a
anchored in the melanosome membrane recruits Mlph, which in
turn recruits myosin Va. Here, we show by reconstitution using
puriﬁed proteins that Rab27a and Mlph are suﬃcient to form
a transport complex with myosin Va in vitro. These results sug-
gest that additional proteins are not required in vivo for assembly
of the myosin Va receptor, although other proteins may associate
with this tripartite complex to regulate its activity and/or to as-
sist Rab27a in anchoring the complex to the melanosome
membrane.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Little is known about how motor proteins attach to their
vesicular cargo. The ﬁrst molecular description of such an
attachment for a myosin motor was published in 2002, when
several groups demonstrated that myosin Va attaches to mela-
nosomes via a two-component receptor complex consisting of
Rab27a anchored in the melanosome membrane and melano-
philin (Mlph), which bridges the interaction between Rab27a
and myosin Va by binding to Rab27a in a GTP-dependent
manner and to myosin Va in an exon F-dependent manner
(exon F being a 25-residue exon speciﬁc to the melanocyte-
spliced heavy chain isoform of myosin Va) [1–4]. In this way,
the tripartite complex of Rab27a, Mlph and myosin Va con-
nects the melanosome to the actin cytoskeleton, a connection
required for the normal accumulation of the organelle in den-
dritic tips. Melanocytes isolated from mice lacking any one of
these three components (i.e. dilutemice (myosin Va null), ashen
mice (Rab27a null) and leaden mice (Mlph null)) exhibit iden-
tical defects in melanosome distribution (perinuclear accumu-
lation), and no additional defects in melanosome distributionAbbreviations: ABS, actin binding site; DA, dominant active; GFP,
green ﬂuorescent protein; melanophilin, Mlph; TIRFM, total internal
reﬂection ﬂuorescence microscopy; WT, wild-type
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doi:10.1016/j.febslet.2006.09.047are observed in melanocytes isolated from double and triple
mutants [1–4]. While these studies established that Rab27a
and Mlph are both required in vivo to form the melanosome
receptor for myosin Va, they did not demonstrate that they
are also suﬃcient to form a fully functional receptor. To begin
to address this issue, we sought here to determine by in vitro
reconstitution and total internal reﬂection ﬂuorescence micros-
copy (TIRFM)-based motility assays whether Rab27a and
Mlph are suﬃcient to form a transport complex with myosin
Va. Our results show that these three proteins are suﬃcient
to form a transport complex whose movement we visualized
using GFP attached to Rab27a.2. Materials and methods
2.1. Proteins
The expression and puriﬁcation of full length, FLAG-tagged myosin
Va (brain and melanocyte-spliced isoforms) and full length, FLAG-
tagged Mlph (WT and D ABS) from Sf9 cells was described previously
[1,5]. The PCR-based fusion of Rab27a (WT and DA) to the C-termi-
nus of EGFPC1, the cloning of this PCR product into pET28a, the
expression of the resulting recombinant, histidine-tagged GFP-Rab27a
fusion protein in Escherichia coli strain BL21, and the puriﬁcation of
the protein on nickel agarose, were all performed using standard tech-
niques. For preparation of GFP-Rab27a-DA loaded with GTPcS, bac-
teria from a 150 ml expression culture were broken by two rounds in a
french press in 10 ml of Buﬀer A (300 mM NaCl, 2 mM MgCL2,
50 mM NaH2PO4, 10 mM imidazole, pH 8.0, and 300 lM GTPcS)
supplemented with protease inhibitors. Triton X-100 was added to a
ﬁnal concentration of 0.4%, and the lysate clariﬁed by centrifugation
at 12000 · g for 15 min. The supernatant was mixed for 3 h with
0.4 ml of Ni-NTA agarose (Qiagen), the resin washed with Buﬀer A
containing 20 mM imidazole, and the visibly green GFP-Rab27a fu-
sion protein eluted with 1.5 ml of Buﬀer A containing 250 mM imidaz-
ole. The fusion protein was then dialyzed over night against 400 ml of
buﬀer containing 80 mMNaCl, 20 mM Tris (pH 7.5), 1.0 mMMgCL2,
and 100 lM GTPcS. To generate complexes between GFP-Rab27a-
DA and Mlph, 100 ll of M2 resin charged with FLAG-tagged Mlph
was mixed for 4 h with 1 ml of dialyzed GFP-Rab27a-DA GFP fusion
protein (this typically represented about 10 GFP-Rab27a molecules
per molecule of bead-associated Mlph, based on quantitative densi-
tometry). The M2 beads were then washed with a buﬀer containing
80 mM NaCl, 20 mM Tris (pH 7.5), 1.0 mM MgCL2 and 50 lM
GTPcS. The complexes were eluted with 100 ll of a buﬀer containing
150 mM NaCl, 20 mM Tris (pH 7.5), 1.0 mM MgCL2,, 0.4 mg/ml
FLAG peptide, and 25 lM GTPcS. We note that no GFP-Rab27a-
DA fusion protein bound to M2 beads alone. The preparation of
GFP-Rab27a-WT loaded with GDP was performed as just described
except that the lysis, dialysis, M2 bead wash and M2 bead elution buf-
fers contained 500, 200, 50 and 25 lM GDP, respectively. In one
experiment, we added an additional step to further facilitate the load-
ing of GFP-Rab27a-WT with GDP. We used a speciﬁc method that isblished by Elsevier B.V. All rights reserved.
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methods that rely on high concentrations of EDTA are not. Brieﬂy,
resin-bound GFP-Rab27a-WT that had already been puriﬁed in the
continual presence of GDP was incubated in 1 M quanidine–HCL
for 1 min on ice to strip bound nucleotide. The resin was then rapidly
pelleted and suspended it in buﬀer containing 500 lMGDP. The label-
ing of calmodulin with Cy3 and the exchange of this calmodulin into
myosin Va was performed as described previously [6]. Quantitative
densitometry was performed on Coomassie blue-stained SDS–PAGE
gels using an Odyssey scanner.2.2. Motility assays and TIRFM
The puriﬁcation of rabbit skeletal muscle actin, the labeling of G-
actin with biotin, the preparation of motility ﬂow cells containing actin
ﬁlaments bound via steptavidin, and TIRFM were all performed
exactly as described previously [6].Fig. 1. Mlph: GFP-Rab27a complexes. Shown is a Coomassie blue-
stained, 10% SDS–PAGE gel of the indicated Mlph: GFP-Rab27a
complexes. The Mlph: GFP-Rab27a-WT(GDP*) complex shown in
lane 5 was prepared using GFP-Rab27a-WT fusion protein that
received an additional step to facilitate the loading of GDP (see
Section 2). The identity of the 25 kDa band is not known.3. Results and discussion
Full length, FLAG-tagged versions of myosin Va (brain and
melanocyte-spliced isoforms) and Mlph were expressed in Sf9
cells and puriﬁed as described previously [1,5]. Wild-type
(WT) Rab27a, as well as a GTPase-deﬁcient, dominant active
(DA) version containing the point mutation Q78L, were
expressed in non-geranylated form in E. Coli as C-terminal
fusions to the green ﬂuorescent protein (GFP) and puriﬁed
on Ni-NTA agarose by means of an N-terminal histidine tag
provided by the pET 28a vector. To maximize the possibility
in initial experiments of forming a functional transport com-
plex, we started with the dominant active mutant of Rab27a
(GFP-Rab27a-DA), as this version should be easier than the
wild-type protein to obtain in the GTP-bound state. E. Coli
expressing GFP-Rab27a-DA were broken in the presence of
a high concentration of the non-hydrolysable GTP-analog
GTPcS and the 57 kDa GFP-Rab27a-DA fusion protein
was puriﬁed in the continual presence of GTPcS.
Our approach to creating the ﬁnal tripartite transport com-
plex of Rab27a, Mlph and myosin Va was to ﬁrst generate a
complex between GFP-Rab27a-DA and Mlph. To accomplish
this, anti-FLAG M2 beads charged with Mlph were incubated
with a solution containing an approximately 10-fold molar ex-
cess of GFP-Rab27a-DA, the beads were washed, and the
complex of Mlph and Rab27a (Mlph: GFP-Rab27a-DA)
eluted from the beads with FLAG peptide. Fig. 1 (lane1)
shows a gel of a typical Mlph: GFP-Rab27a-DA complex
(the average starting concentration of the complex was
0.5 mg/ml). Assuming equal avidity for Coomassie blue,
quantitative densitometry indicated that the complex con-
tained on average 0.8 molecules of GFP-Rab27a-DA for
every Mlph molecule.
To characterize the Mlph: GFP-Rab27a-DA complex in
more detail, we measured the bleaching kinetics of individual
complexes bound statically to the surface of the motility ﬂow
cell and imaged by TIRFM. Panels A–C in Fig. 2 show from
top to bottom the raw bleaching data for three individual com-
plexes in which the total ﬂuorescence of the complex disap-
peared in 3, 2 and 1 steps, respectively. Analysis of 200
randomly-selected Mlph: GFP-Rab27a-DA complexes indi-
cated that complexes can contain between 1 and 5 GFP-
Rab27a-DAmolecules, that the most common complex present
(50% of the total) contains 1 GFP-Rab27a-DA molecule, and
that less that25% of the complexes contain more than 2 GFP-
Rab27a-DA molecules (Fig. 2, panel D). While these measure-ments allowed us to estimate the approximate number of GFP-
Rab27a molecules present in individual transport complexes
moving along actin ﬁlaments (see below), the exact number
of unlabelled Mlph molecules present in these complexes is
unknown. Moreover, the number of myosin Va molecules
present in complete tripartite transport complexes (see below)
was either completely unknown when unlabelled myosin Va
was used, or diﬃcult to estimate when labeled myosin Va
was used (due to the variable exchange of Cy3-labelled cal-
modulin into the myosin). These issues can only be resolved
by using all three proteins labeled to homogeneous stoichiom-
etry with three diﬀerent and resolvable ﬂuorophores. While we
did not attempt this, knowledge of the exact stoichiometry of
components in the transport complexes formed here is not
required to reach our main conclusion (i.e. that Rab27a, Mlph
and myosin Va are suﬃcient to form a transport complex
in vitro). By contrast, future examination of issues such as pos-
sible changes in the processivity of myosin Va upon cargo
binding will require knowledge of the exact stoichiometry of
all three components in the particular transport complex being
measured.
To assemble and visualize a complete tripartite transport
complex, 10 nM Mlph: GFP-Rab27a-DA complex was mixed
with an equal volume of 10 nM unlabelled myosin Va (the
exon-F-containing melanocyte-spliced isoform unless stated
otherwise) and the mixture was loaded into our standard
TIRFM motility assay ﬂow cell containing unlabelled actin ﬁl-
aments bound to the bottom cover glass surface [6]. Time lapse
imaging of the GFP on Rab27a at 3.3 frames per second (fps)
in TIRFM mode routinely showed robust movement of many
GFP spots throughout the ﬁeld of view (see Supplementary
Movie 1). Use of actin ﬁlaments labeled with rhodamine-phal-
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Fig. 2. Bleaching kinetics of Mlph: GFP-Rab27a-DA complexes.
Panels A–C show the bleaching kinetics for three complexes whose
total initial ﬂuorescence disappeared in 3, 2 and 1 bleaching events (top
to bottom). The red lines mark the approximate position of the average
ﬂuorescence intensity at each plateau. Based on the size of the drop in
ﬂuorescence for the ﬁrst bleaching event in A, we assume that this drop
corresponds to the near-simultaneous bleaching of two GFP mole-
cules. Panel D shows a histogram of the number of GFP molecules
present in 200 randomly chosen complexes, as determined by their
bleaching kinetics. There are a number of possible reasons why we
obtain complexes containing more than one Rab27a-GFP molecule:
(1) GFP: GFP dimerization (we did not use monomeric GFP), (2)
dimerization of Mlph (Mlph contains a segment of putative coiled
coil), (3) self-association of Mlph, and/or (4) some non-speciﬁc
aggregation. Even if this last possibility is why we obtain Mlph:
Rab27a complexes with more than one GFP-Rab27a molecule, the
complex with one GFP-Rab27a was the most common species
obtained, and such complexes moved robustly when mixed with
myosin Va.
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along actin. Panel A in Fig. 3 shows a time series (3.6 s inter-
vals) of a GFP-tagged transport complex (now appearing asyellow in color and marked with white arrowheads) moving
along a red actin ﬁlament at 1 lm/s (see also Supplementary
Movie 2). Closer examination of this moving complex, which
we estimate from its ﬂuorescence intensity contained 3 GFP-
Rab27a-DA molecules, revealed a second, dimmer GFP-
tagged transport complex moving just behind it. As shown in
the time series presented in panel B of Fig. 3, this dimer trans-
port complex (marked with yellow arrowheads), which we esti-
mate contained 1 GFP molecule, moved at the same speed as
the brighter complex (marked with white arrowheads; 0.9 s
intervals). While we do not know precisely how many myosin
Va molecules are present in these two complexes, if the number
is diﬀerent (which seems likely), this diﬀerence did not aﬀect
the rate of movement.
To demonstrate that GFP-tagged Rab27a moves coordi-
nately with myosin Va, the myosin was labeled by exchange
of its calmodulin light chains with exogenous, Cy3-tagged cal-
modulin as described previously [6] (in this experiment the
average labeling stoichiometry was one Cy3-calmodulin per
myosin Va molecule). Double-labeled transport complexes
were then formed by mixing this labeled myosin Va with the
Mlph: GFP-Rab27a-DA complex. Panels A–F in Fig. 4 show
the displacement of one such double-labeled complex at 12 s
intervals. The red signal for myosin Va can be seen to move
in precise register with the green signal for GFP-Rab27a (see
the overlay in yellow; panel G shows time series projections
for the red and green signals) (also see Supplementary Movie
3).
To deﬁne the requirements for movement of the tripartite
transport complex, we measured under standardized condi-
tions the number of movements of GFP-Rab27a spots per 3-
min time interval per ﬁeld (4 · 103 lm2) in motility assays
where individual components used to assemble the complete
transport complex or assay its activity were omitted (Table
1). 35 ± 10 movements occurred for the positive control, which
was the complete transport complex formed using unlabelled
myosin Va and the Mlph: GFP-Rab27a-DA complex and as-
sayed in the presence of ATP. As expected, omission of either
myosin Va or ATP completely abrogated the movement of the
Mlph: GFP-Rab27a-DA complex. Most importantly, when we
omitted Mlph from the assay (i.e. when we used free GFP-
Rab27a-DA instead of the Mlph: GFP-Rab27a-DA complex),
we never observed movement of the GFP signal. This was the
case even when we used free GFP-Rab27a-DA at a concentra-
tion 20 times higher than that of GFP-Rab27a-DA present in
the complete transport complex used as the positive control.
Together, these results show that all three proteins (and
ATP) are required to obtain a functional transport complex,
and they conﬁrm that no proteins other than Rab27a, Mlph
and myosin Va are required.
Biochemical data, yeast two hybrid analyses, and functional
studies all show that the interaction of Rab27a with Mlph, like
the interaction of other Rab GTPases with their eﬀector pro-
teins, is GTP-dependent: GTP-bound Rab27a, but not GDP-
bound Rab27a, binds Mlph [1–4]. Consistent with this, when
we prepared the complex of Rab27a and Mlph exactly as de-
scribed above except that we used the WT, GTPase-competent
version of Rab27a and we puriﬁed it in the continual presence
of a high concentration of GDP, we obtained Mlph: GFP-
Rab27a-WT complexes that contained on average only
0.15 molecules of Rab27a per molecule of Mlph (Fig. 1, lane
4). This ratio decreased to 0.06 molecules of Rab27a per
Fig. 3. Reconstitution and movement of the myosin Va receptor complex. Panel A shows a time series of the movement of a tripartite transport
complex (as revealed by GFP-Rab27a-DA) along an actin ﬁlament labeled with rhodamine phalloidin. The white arrowheads mark the position of
this complex at the times indicated (mag bar = 5.1 lm). We note that this tripartite complex moved persistently for over 40 lm, and that the average
speed of such complexes was 1.01 ± 0.30lm/s (N = 17). Panel B shows an enlargement of the region boxed in panel A (mag bar = 3.2 lm). A fainter
transport complex, whose position is marked with yellow arrowheads, can be seen to move in register with the bright complex.
Fig. 4. GFP-tagged Rab27a moves coordinately with myosin Va. Panels A–F show the co migration of Cy3-labeled myosin Va in red and GFP-
Rab27a-DA in green at 12 s intervals (yellow shows the overlap in the two signals). The approximate position of the actin track being used by this
double-labeled transport complex in outlined in white. Panel G shows the time series projections for the two colors (mag bar = 3.1 lm).
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Table 1
Quantitative analyses of the movement of diﬀerent transport complexes
Component Average # of movements
(per 4 · 103 lm2 per 3 min)
# of
measurements
Mean actin ﬁlaments
length ± S.D. (lm)
Actin ﬁlament
number ± S.D.
(per 4 · 103 lm2)
Rab27a Melanophilin Myosin Va ATP
GFP-Rab27a-DA Mlph MCMVaa + 35 ± 10 7 11.3 ± 9.0 23 ± 5
GFP-Rab27a-DA Mlph – + 0 5 11.3 ± 6.9 21 ± 7
GFP-Rab27a-DA Mlph MCMVa  0 6 12.7 ± 8.4 21 ± 12
GFP-Rab27a-DA – MCMVa + 0 5 10.3 ± 8.2 18 ± 7
GFP-Rab27a-DA MlphDABS MCMVa + 3 ± 1 6 9.2 ± 7.2 16 ± 7
GFP-Rab27a-DA Mlph BRMVab + 2 ± 1 5 7.9 ± 5.8 17 ± 5
aMCMVa – Melanocyte-spliced isoform of myosin Va.
bBRMVa – Brain-spliced isoform of myosin Va.
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WT in the presence of GDP, we added an additional step to
facilitate exchange of GDP into Rab27a (Fig. 1, lane 5; see
Section 2 for details). We assume that this small, residual inter-
action of Rab27a with Mlph is due to a small population of
Rab27a that is still loaded with GTP. Moreover, we estimate
that this population of GTP-loaded Rab27a is quite small
given the fact that the complex is formed using a 10-fold molar
excess of the Rab over Mlph.
Biochemical and cell biological assays show that Mlph con-
tains a binding site for F-actin located within its C-terminal
100 residues (490–590), and that changing four closely-
spaced basic residues (K493, R495, R496, K 497) within this
segment to alanines abrogates Mlph’s interaction with actin
[7]. We found that full-length Mlph containing these four point
mutations (Mlph D actin binding site (D ABS)) binds normally
to GFP-Rab27a-DA (Fig. 1, lane 2; 0.8 molecules of Rab27a
per molecule Mlph D ABS). This complex diﬀered from theFig. 5. Decoration of actin by Mlph: Rab27a complexes in the absence of my
DA complexes and F-actin, respectively, while panels C and D show the di
respectively (mag bar = 2.6 lm).wild-type complex, however, in that while the Mlph: GFP-
Rab27a-DA complex usually showed clear alignment with
actin ﬁlaments when added to the motility assay in the absence
of myosin Va (Fig. 5A and B), the Mlph D ABS: GFP-Rab27a-
DA complex never did (Fig. 5C and D). We also note that
actin-bound Mlph: GFP-Rab27a-DA complexes were com-
pletely stationary and typically persisted in the TIRF ﬁeld
for many minutes. This slow ‘‘oﬀ’’ rate likely implies a high
aﬃnity of Mlph for F-actin. Most importantly, we found that
tripartite transport complexes made using Mlph D ABS exhib-
ited a greatly reduced frequency of movement relative to com-
plexes made under identical conditions using WT Mlph (Table
1). Motile events that did occur using Mlph D ABS moved at a
normal speed, however (0.86 ± 0.3 lm/s (N = 3); see Supple-
mentary Movie 4). Finally, when myosin Va was added to
Mlph: GFP-Rab27a-DA complexes already bound to actin,
some individual complexes could be seen to transition seam-
lessly from motionless to movement at 1 l/s without everosin Va. Panels A and B show the distribution of Mlph: GFP-Rab27a-
stribution of Mlph D ABS: GFP-Rab27a-DA complexes and F-actin,
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results, if we assume that the actin binding site mutation in
Mlph does not interfere with Mlph’s interaction with myosin
Va (an assumption supported by previous data [7]), then the
results in Table 1 suggest that the ability of Mlph to bind actin
directly enhances the frequency of interactions between myosin
Va and actin that result in movement of the tripartite complex.
These results also demonstrate that Mlph’s actin binding site is
not required for movement of the tripartite transport complex,
and suggest that Mlph: actin interaction does not impede in
any obvious way the movement of the tripartite complex, since
tripartite complexes made using Mlph D ABS do not move fas-
ter than complexes made using WTMlph. Finally, the fact that
myosin Va can move Mlph: Rab27a complexes previously
bound to actin argues that the myosin can interact with
actin-associated Mlph as well as with Mlph in solution. This
observation may be relevant to published results showing that
Mlph’s actin binding site, as well as the actin binding site in
MyRIP, a related adaptor protein that links Rab27a to myosin
VII, is important for function in vivo [7,8]. Deﬁning the precise
mechanism by which Mlph’s actin binding site augments the
frequency of motile events exhibited by the tripartite transport
complex, the signiﬁcance of this eﬀect in terms of melanosome
movement in vivo, and whether Mlph’s ability to bind to actin
augments myosin Va’s processivity, will all require further
study. Relevant to this latter point, dynactin has been shown
to augment dynein’s processivity through its ability to interact
with the microtubule [9,10].
Myosin Va binds to Mlph through a low aﬃnity interaction
mediated by its globular tail domain (GTD) [11] and a high
aﬃnity interaction mediated by exon F, a 25-residue insert
present in the melanocyte-spliced isoform of myosin Va but
not the brain-spliced isoform [1–4,11]. Consistent with this, tri-
partite complexes made using GFP-Rab27a-DA and the brain-
spliced isoform, which should be capable of binding Mlph only
through the low aﬃnity, GTD-dependent site, exhibited only
very sporadic movements on actin (Table 1) which on average
appeared to be shorter than those seen using the melanocyte-
spliced isoform (see Supplementary Movie 5).
In summary, the data presented here argue that Rab27a and
Mlph are not only required to form the melanosome receptor
for myosin Va, they are also suﬃcient to form the receptor.
That said, other proteins might associate with this receptor
complex to regulate its activity and/or to assist Rab27a in
anchoring the complex to the melanosome membrane. To
our knowledge, this is the ﬁrst demonstration of the movement
of an actin-based motor while in a complex with its organelle
receptor. Future eﬀorts should seek to substitute the ‘‘cargo’’
used here (GFP) with a more physiological cargo (e.g. vesicle).More speciﬁcally, these eﬀorts should attempt to link Rab27a
to the vesicle via its geranylgeranyl groups.
Acknowledgements: We thank Kirsten Remmert and Wolfgang Wag-
ner for help with the baculovirus work.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.
2006.09.047.References
[1] Wu, X.S., Rao, K., Zhang, H., Wang, F., Sellers, J.R., Matesic,
L.E., Copeland, N.G., Jenkins, N.A. and Hammer III, J.A. (2002)
Identiﬁcation of an organelle receptor for myosin-Va. Nat. Cell
Biol. 4, 271–277.
[2] Fukuda, M., Kuroda, T.S. and Mikoshiba, K. (2002) Slac2-a/
Mlph, the missing link between Rab27 and myosin Va: implica-
tions of a tripartite protein complex for melanosome transport. J.
Biol. Chem. 227, 12432–12436.
[3] Strom, M., Hume, A.N., Tarafder, A.K., Barkagianni, E. and
Seabra, M.C. (2002) A family of Rab27-binding proteins.
Melanophilin links Rab27a and myosin Va function in melano-
some transport. J. Biol. Chem. 227, 25423–25430.
[4] Nagashima, K., Torii, S., Yi, Z., Igarashi, M., Okamoto, K.,
Takeuchi, T. and Izumi, T. (2002) Melanophilin directly links
Rab27a and myosin Va through its distinct coiled–coil regions.
FEBS Lett. 517, 233–238.
[5] Wu, X.S., Tsan, G.L. and Hammer III, J.A. (2005) Melanophilin
and myosin Va track the microtubule plus end on EB1. J. Cell
Biol. 171, 201–207.
[6] Sakamoto, T., Yildiz, A., Selvin, P.R. and Sellers, J.R. (2003)
Step-size is determined by neck length in myosin V. Biochemistry
44, 16203–16210.
[7] Kuroda, T.S., Ariga, H. and Fukuda, M. (2003) The actin-
binding domain of Slac2-a/Mlph is required for melanosome
distribution in melanocytes. Mol. Cell Biol. 23, 5245–5255.
[8] Desnos, C., Schonn, J.S., Huet, S., Tran, V.S., El-Amraoui, A.,
Raposo, G., Fanget, I., Chapuis, C., Menasche, G., de Saint-
Basile, G., Petit, C., Cribier, S., Henry, J.P. and Darchen, F.
(2003) Rab27a and its eﬀector MyRIP link secretory granules to
F-actin and control their motion towards release sites. J. Cell Biol.
163, 559–570.
[9] King, S.J. and Schroer, T.A. (2000) Dynactin increases the
processivity of the cytoplasmic dynein motor. Nat. Cell Biol. 2,
20–24.
[10] Culver-Hanlon, T.L., Lex, S.A., Stephens, A.D., Quintyne, N.J.
and King, S.J. (2006) A microtubule-binding domain in dynactin
increases dynein processivity by skating along microtubules. Nat.
Cell Biol. 8, 264–270.
[11] Fukuda, M. and Kuroda, T.S. (2004) Missense mutations in the
globular tail of myosin-Va in dilute mice partially impair binding
of Slac2-a/Mlph. J. Cell Sci. 117, 583–591.
